
Tata Motors Commercial Vehicles reported an 83% year-on-year rise in consolidated net profit to Rs 2,560 crore for Q1FY27, aided by a mark-to-market gain on its Tata Capital investment. Revenue rose 19%…
Tata Motors Commercial Vehicles reported an 83% year-on-year rise in consolidated net profit to Rs 2,560 crore for Q1FY27, aided by a mark-to-market gain on its Tata Capital investment. Revenue rose 19% to Rs 20,667 crore. Apollo Hospitals' consolidated profit after tax jumped 38.4% to Rs 610.4 crore, driven by healthcare services growth. Grasim Industries posted a 39% rise in consolidated PAT to Rs 3,846.28 crore.

Other notable results: VA Tech Wabag's standalone PAT stood at Rs 79.3 crore, Lenskart Solutions' PAT rose 45% to Rs 151.48 crore, and Hindustan Aeronautics reported a 15% rise in standalone PAT to Rs 1,580.61 crore. Eureka Forbes saw a 44% increase in standalone PAT, while Gujarat Fluorochemicals' PAT grew 8.6% to Rs 201 crore. The Bombay Stock Exchange's Sensex closed 188 points lower at 77,966.

This earnings season is being spun as a sign of an unalloyed boom, but the truth is more uneven. Apollo's 34% profit rise is on the back of a services sector still recovering from pandemic lows, while Tata Motors' 83% jump includes a one-time mark-to-market gain on its Tata Capital investment. Exclude that, and the picture for core auto margins is less spectacular. The real test is not the headline number but cash flow from operations and debt reduction across these companies. Will Q2 show sustainable demand or just a sugar rush from one-off gains?
Source: thehindubusinessline.com
This story was synthesised by AI from the source linked above.